Home » Topics » Conferences

Conferences
RSS

Hughes Institute prepares novel NNRTIs useful as microbicidal spermicides

April 9, 1999

Didox outperforms hydroxyurea in murine AIDS model

April 9, 1999

Preclinical results indicate potential value of clevudine in chronic HBV infections

April 9, 1999

Anti-CMV activity of BDCRB evaluated in newly designed preclinical model

April 9, 1999

RPR-CMV-423: a promising candidate for treatment of human CMV infection

April 9, 1999

Selective, orally active beta3-adrenoceptor agonists identified at Merck

April 9, 1999

Corvas reports design, synthesis and activity of selective peptidomimetic uPA inhibitors

April 9, 1999

New class of potent, selective human glucagon receptor antagonists presented by Merck

April 9, 1999

U. Penn team synthesizes novel analogues of Ritalin for treatment of cocaine addiction

April 9, 1999

E-047/1 more effective than known antiarrhythmics against ventricular fibrillation

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...